In conclusion, β-sitosterol exhibits anti-RA activity via multiple targets (MMP9, CASP3, HSP90AA1, SRC, EGFR, and ALB) and signaling pathways (FoxO and PI3K/AKT pathways). Here, AKT1 is linked to rheumatoid arthritis.